{"id":396,"date":"2026-03-06T17:02:36","date_gmt":"2026-03-06T21:02:36","guid":{"rendered":"https:\/\/seidenbenefits.com\/News\/?p=396"},"modified":"2026-03-06T17:02:37","modified_gmt":"2026-03-06T21:02:37","slug":"7-mistakes-youre-making-with-glp-1-coverage-and-how-to-fix-them","status":"publish","type":"post","link":"https:\/\/seidenbenefits.com\/News\/7-mistakes-youre-making-with-glp-1-coverage-and-how-to-fix-them\/","title":{"rendered":"7 Mistakes You\u2019re Making with GLP-1 Coverage (and How to Fix Them)"},"content":{"rendered":"As your broker and dedicated partner in navigating the ever-evolving insurance landscape, I am working daily to help you balance employee satisfaction with bottom-line sustainability. Right now, the most significant challenge facing many of our clients involves the meteoric rise of GLP-1 medications like Wegovy, Zepbound, and Ozempic.\n\nWhile these drugs offer transformative health benefits for employees struggling with obesity and type 2 diabetes, they also present a substantial financial risk if not managed correctly. If you are noticing a spike in your pharmacy spend or are considering adding weight loss coverage to your 2026 plan, you must avoid the common pitfalls that lead to “budget shock.”\n\nI am here to guide you through the 7 most common mistakes<\/strong> employers make with GLP-1 coverage and, more importantly, how you can implement actionable solutions today.\n\n
\n\n

1. Implementing an “Open Door” Policy Without Guardrails<\/h3>\nThe biggest mistake I see is offering GLP-1 coverage as a “blank check.” When an employer adds weight loss drug coverage without specific restrictions, the utilization often exceeds projections within the first 90 days<\/strong>.\n\nThe Fix: Robust Prior Authorization (PA)<\/strong>\nYou must implement a strict Prior Authorization process. This ensures that only employees who meet specific medical criteria receive the medication. As your broker, I recommend working with your Pharmacy Benefit Manager (PBM) to require that a physician provides clinical proof of medical necessity before the first dose is dispensed. You can learn more about how we structure these plans on our Services page<\/a>.\n

2. Ignoring Specific Clinical Eligibility Criteria<\/h3>\nNot everyone who wants to lose ten pounds for a summer wedding is a candidate for a $1,000-per-month clinical intervention. Many plans fail because they do not define “eligibility” clearly enough, leading to “lifestyle” use rather than “medical” use.\n\nThe Fix: Align with FDA Guidelines<\/strong>\nYour plan should strictly adhere to FDA-approved indications. Generally, this means coverage is limited to individuals with a Body Mass Index (BMI) of 30 or higher<\/strong>, or a BMI of 27 or higher with at least one weight-related comorbidity<\/strong> (such as hypertension or high cholesterol). By codifying these numbers into your plan documents, you protect your budget from inappropriate utilization.\n\n\"Doctor\n

3. Disconnecting Medication from Behavioral Support<\/h3>\nGLP-1s are not a “magic pill” that works in a vacuum. Clinical data suggests that weight regain is highly likely once the medication is discontinued if the patient hasn’t made lifestyle changes. Providing the drug without a wellness component is a short-term fix that leads to long-term expense.\n\nThe Fix: Integrated Wellness Programs<\/strong>\nI suggest making coverage “contingent” on participation in a lifestyle modification program. This might include digital health coaching, nutritional counseling, or regular fitness tracking. When you wrap the medication in a comprehensive wellness framework, you are investing in a permanent health outcome rather than a temporary prescription.\n

4. Overlooking the “Step Therapy” Approach<\/h3>\nSome employers jump straight to the most expensive, brand-name GLP-1s without exploring lower-cost alternatives that might be just as effective for certain patients.\n\nThe Fix: Phased Clinical Protocols<\/strong>\nBefore approving a top-tier GLP-1 for weight loss, your plan can require Step Therapy<\/strong>. This means the member must first try lower-cost, evidence-based interventions or medications, or demonstrate that they are already participating in a supervised weight management program. This “step-up” approach ensures that the most expensive resources are reserved for those who truly need them.\n

5. Failing to Plan for the “Off-Ramp”<\/h3>\nMost benefits plans focus on how to start a member on a GLP-1, but very few have a strategy for when to stop. Without a “maintenance” or “discontinuation” strategy, your plan could be paying for maximum dosages indefinitely.\n\nThe Fix: Re-Authorization Requirements<\/strong>\nI am working with clients to implement re-authorization milestones<\/strong>. For example, an employee might be approved for an initial six months. To get a renewal, they must demonstrate a 5% to 10% weight loss<\/strong>. If the medication isn’t working effectively for that specific individual, the coverage should cease. This ensures you are only paying for results.\n\n\"Fitness\n

6. Turning to Compounded Medications Due to Cost<\/h3>\nWith the high cost of brand-name GLP-1s, some employers are tempted to cover “compounded” versions of semaglutide or tirzepatide from specialized pharmacies. While cheaper, this is a significant risk.\n\nThe Fix: Prioritize FDA-Approved Safety<\/strong>\nCompounded drugs do not undergo the same rigorous FDA safety and efficacy testing as brand-name drugs. As your trusted advisor, I caution against this. The potential for dosing errors and liability issues far outweighs the initial cost savings. Stick to FDA-approved medications and focus your savings efforts on utilization management<\/strong> and negotiated rebates<\/strong> instead.\n

7. Poor Communication and Lack of Transparency<\/h3>\nWhen employees find out their “weight loss benefit” comes with strings attached at the pharmacy counter, it creates frustration and HR headaches.\n\nThe Fix: Clear Employee Education<\/strong>\nTransparency is key. We should work together to create clear communication materials that explain why<\/em> these guardrails exist. When employees understand that the goal is long-term health and plan sustainability, they are more likely to cooperate with the PA process. If you need assistance drafting these communications, please reach out via our Contact Form<\/a>.\n\n
\n\n

The Path Forward: A Phased Rollout Strategy<\/h3>\nAs a reminder, you don’t have to tackle this all at once. If you are concerned about the financial impact of GLP-1s, we can discuss a Phased Rollout<\/strong>. This allows you to introduce coverage to your highest-risk populations first, monitor the spend, and then expand the benefit as your budget allows.\n\nI am monitoring the 2026 pharmacy trends daily to ensure Seiden Benefits clients have the most up-to-date data. The landscape is shifting quickly, new competitors are entering the market, and prices will eventually fluctuate. Staying agile is your best defense.\n

How We Can Help Today<\/h3>\nManaging high-cost specialty drugs requires a delicate balance of clinical expertise and financial strategy. I am here to help you review your current pharmacy spend, analyze your employee demographics, and craft a GLP-1 strategy that makes sense for your business.\n\nAs always, I am here to help.<\/strong> If you have questions about your specific plan design or want to see a projection of how these drugs might impact your upcoming renewal, let\u2019s schedule a time to talk. You can view our full range of insurance solutions on our Products page<\/a>.\n\nWe are in this together, and I look forward to helping you build a healthier, more sustainable benefits package for your team.\n\n#GLP1 #EmployeeBenefits #HealthInsurance #SeidenBenefits\n\n\"Seiden\n\n
\n\nDisclaimer: This blog post is for informational purposes only and does not constitute legal or medical advice. Please consult with your legal counsel and clinical advisors before making significant changes to your employee benefits plan.<\/em>","protected":false},"excerpt":{"rendered":"As your broker and dedicated partner in navigating the ever-evolving insurance landscape, I am working daily to help you balance employee satisfaction with bottom-line sustainability. Right now, the most significant challenge facing many of our clients involves the meteoric rise … Read more<\/a>","protected":false},"author":1,"featured_media":395,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-396","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/posts\/396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/comments?post=396"}],"version-history":[{"count":1,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/posts\/396\/revisions"}],"predecessor-version":[{"id":397,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/posts\/396\/revisions\/397"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/media\/395"}],"wp:attachment":[{"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/media?parent=396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/categories?post=396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seidenbenefits.com\/News\/wp-json\/wp\/v2\/tags?post=396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}